Management algorithm for genotype 1 hepatitis C virus

por Kim, Arthur Y.
Publicado 2013

Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2: What Goes Around May Come Back Around

por Kim, Arthur Y, Gandhi, Rajesh T
Publicado 2020

Desperate Times Call for Temperate Measures: Practicing Infectious Diseases During a Novel Pandemic

por Siedner, Mark J, Gandhi, Rajesh T, Kim, Arthur Y
Publicado 2020

The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets

por Morgan, Jake R, Kim, Arthur Y, Naggie, Susanna, Linas, Benjamin P
Publicado 2017

Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange Programs

por Barocas, Joshua A., Linas, Benjamin P., Kim, Arthur Y., Fangman, John, Westergaard, Ryan P.
Publicado 2016

Bebtelovimab for High-Risk Outpatients With Early COVID-19 in a Large US Health System

por Dryden-Peterson, Scott, Kim, Andy, Joyce, Mary-Ruth, Johnson, Jennifer A, Kim, Arthur Y, Baden, Lindsey R, Woolley, Ann E
Publicado 2022

Peginterferon lambda for the treatment of hospitalized patients with mild COVID-19: A pilot phase 2 randomized placebo-controlled trial

por Kim, Myung-Ho, Elbaz, Josh, Jilg, Nikolaus, Gustafson, Jenna L., Xu, Min, Hatipoglu, Dilara, Nohelty, Eric, Kim, Arthur Y., Chung, Raymond T.
Publicado 2023

Short and Long-Term Effects of Telaprevir on Kidney Function in Patients with Hepatitis C Virus Infection: A Retrospective Cohort Study

por Sise, Meghan E., Backman, Elke S., Wenger, Julia B., Wood, Brian R., Sax, Paul E., Chung, Raymond T., Thadhani, Ravi, Kim, Arthur Y.
Publicado 2015

ADCC-Mediated CD56(DIM) NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection

por Yu, Wen-Han, Cosgrove, Cormac, Berger, Christoph T, Cheney, Patrick C, Krykbaeva, Marina, Kim, Arthur Y, Lewis-Ximenez, Lia, Lauer, Georg M, Alter, Galit
Publicado 2018

Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions

por Meyerowitz, Eric A, Sen, Pritha, Schoenfeld, Sara R, Neilan, Tomas G, Frigault, Matthew J, Stone, John H, Kim, Arthur Y, Mansour, Michael K
Publicado 2020

Evaluation of Hepatitis C Treatment Outcomes Among Patients Enrolled in Outpatient Parenteral Antibiotic Therapy—Boston, Massachusetts, 2016–2021

por Gupta, Akash, Ashour, Dina, Shebl, Fatma M, Platt, Laura, Chiosi, John J, Nelson, Sandra B, Ard, Kevin L, Kim, Arthur Y, Bassett, Ingrid V
Publicado 2023

The Hepatitis C Cascade of Care: Identifying Priorities to Improve Clinical Outcomes

por Linas, Benjamin P., Barter, Devra M., Leff, Jared A., Assoumou, Sabrina A., Salomon, Joshua A., Weinstein, Milton C., Kim, Arthur Y., Schackman, Bruce R.
Publicado 2014

Chronic HCV Infection Affects the NK Cell Phenotype in the Blood More than in the Liver

por Cosgrove, Cormac, Berger, Christoph T., Kroy, Daniela C., Cheney, Patrick C., Ghebremichael, Musie, Aneja, Jasneet, Tomlinson, Michelle, Kim, Arthur Y., Lauer, Georg M., Alter, Galit
Publicado 2014

Rethinking the role of hydroxychloroquine in the treatment of COVID‐19

por Meyerowitz, Eric A., Vannier, Augustin G. L., Friesen, Morgan G. N., Schoenfeld, Sara, Gelfand, Jeffrey A., Callahan, Michael V., Kim, Arthur Y., Reeves, Patrick M., Poznansky, Mark C.
Publicado 2020

Peripheral blood iNKT cell activation correlates with liver damage during acute hepatitis C

por Senff, Tina, Menne, Christopher, Cosmovici, Christine, Lewis-Ximenez, Lia Laura, Aneja, Jasneet, Broering, Ruth, Kim, Arthur Y., Westendorf, Astrid M., Dittmer, Ulf, Scherbaum, Norbert, Lauer, Georg M., Timm, Jörg
Publicado 2022

Nirmatrelvir plus ritonavir for early COVID-19 and hospitalization in a large US health system

por Dryden-Peterson, Scott, Kim, Andy, Kim, Arthur Y., Caniglia, Ellen C., Lennes, Inga, Patel, Rajesh, Gainer, Lindsay, Dutton, Lisa, Donahue, Elizabeth, Gandhi, Rajesh T., Baden, Lindsey R., Woolley, Ann E.
Publicado 2022

Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1

por Linas, Benjamin P., Morgan, Jake R., Pho, Mai T., Leff, Jared A., Schackman, Bruce R., Horsburgh, C. Robert, Assoumou, Sabrina A., Salomon, Joshua A., Weinstein, Milton C., Freedberg, Kenneth A., Kim, Arthur Y.
Publicado 2016

Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration

por Morris, Meghan D., Shiboski, Stephen, Bruneau, Julie, Hahn, Judith A., Hellard, Margaret, Prins, Maria, Cox, Andrea L., Dore, Gregory, Grebely, Jason, Kim, Arthur Y., Lauer, Georg M., Lloyd, Andrew, Rice, Thomas, Shoukry, Naglaa, Maher, Lisa, Page, Kimberly
Publicado 2017

Impaired Hepatitis C Virus-Specific T Cell Responses and Recurrent Hepatitis C Virus in HIV Coinfection

por Kim, Arthur Y, Schulze zur Wiesch, Julian, Kuntzen, Thomas, Timm, Joerg, Kaufmann, Daniel E, Duncan, Jared E, Jones, Andrea M, Wurcel, Alysse G, Davis, Benjamin T, Gandhi, Rajesh T, Robbins, Gregory K, Allen, Todd M, Chung, Raymond T, Lauer, Georg M, Walker, Bruce D
Publicado 2006

CD8 Epitope Escape and Reversion in Acute HCV Infection

por Timm, Joerg, Lauer, Georg M., Kavanagh, Daniel G., Sheridan, Isabelle, Kim, Arthur Y., Lucas, Michaela, Pillay, Thillagavathie, Ouchi, Kei, Reyor, Laura L., zur Wiesch, Julian Schulze, Gandhi, Rajesh T., Chung, Raymond T., Bhardwaj, Nina, Klenerman, Paul, Walker, Bruce D., Allen, Todd M.
Publicado 2004